Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children

Overview

The aim of the study is to evaluate the risk in intra-operative nasal hemorrhage when using a "pushed" probe (Master Ka) in the treatment of naso lacrimal duct obstruction (NLDO). In the investigator's experience, this risk seemed to minus using a pushed probe rather than the classical pulled-type probes. A lower risk of hemorrhage could lead to a change in the anesthetic procedure. The gold standard in NLDO is the use of an orotracheal intubation. It could then be replaced by the use of an orolaryngeal mask. A forthcoming study will evaluate the results of this anesthetic change.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 11, 2019

Interventions

  • Procedure: “pushed” mono-canaliculonasal intubation

Arms, Groups and Cohorts

  • Nasolacrimal duct obstruction

Clinical Trial Outcome Measures

Primary Measures

  • Nasal hemorrhage
    • Time Frame: Through surgery completion, an average of 1 hour

Participating in This Clinical Trial

Inclusion Criteria

  • < 6 years of age – Unilateral lacrimal duct obstruction with programmed surgery – Surgery scheduled wih a "pushed" mono-canaliculonasal intubation – No opposition of parents for he participation of their child Exclusion Criteria:

  • Coagulation disorder – Previous history of nasolacrimal intubation (homo or contra-lateral) – Non covered by health insurance

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: 6 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fondation Ophtalmologique Adolphe de Rothschild
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.